Delirium, Dementia, Amnestic, Cognitive Disorders  >>  Cereact (arundic acid)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cereact (arundic acid) / Ono Pharma
NCT00083421: Effects of ONO-2506PO in Patients With Alzheimer's Disease

Completed
2
647
US, Canada
ONO-2506PO
Ono Pharma USA Inc
Alzheimer's Disease
 
07/07

Download Options